Join Growin Stock Community!

福永生技4183.TW Overview

TW StockBiotech. & Medical
(No presentation for 4183)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

福永生技（4183）Overall Performance

福永生技（4183）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

福永生技（4183） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

福永生技（4183）Key Information

福永生技（4183）Profile

EPS Bio Technology Corp. manufactures and sells OEM/ODM blood glucose system in Taiwan. It also provides test strip; diabetic self-monitoring blood glucose systems under the EASYMAX and MDT2 BLE name; and wearable, and NFC and Bluetooth connectivity blood glucose monitors. The company was founded in 2006 and is headquartered in Hsinchu City, Taiwan.

福永生技（4183）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.60
PE Ratio (TTM)
-
Forward PE
36.48
PS Ratio (TTM)
0.77
PB Ratio
1.35
Price-to-FCF
13.01
METRIC
VALUE
vs. INDUSTRY
Gross Margin
15.20%
Net Margin
-2.86%
Revenue Growth (YoY)
2.51%
Profit Growth (YoY)
-41.87%
3-Year Revenue Growth
-3.74%
3-Year Profit Growth
-14.48%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.60
PE Ratio (TTM)
-
Forward PE
36.48
PS Ratio (TTM)
0.77
PB Ratio
1.35
Price-to-FCF
13.01
Gross Margin
15.20%
Net Margin
-2.86%
Revenue Growth (YoY)
2.51%
Profit Growth (YoY)
-41.87%
3-Year Revenue Growth
-3.74%
3-Year Profit Growth
-14.48%
default symbol

4183

福永生技

16.05D

-0.62%

(-0.01)

  • When is 4183's latest earnings report released?

    The most recent financial report for 福永生技 (4183) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 4183's short-term business performance and financial health. For the latest updates on 4183's earnings releases, visit this page regularly.

  • What is the operating profit of 4183?

    According to the latest financial report, 福永生技 (4183) reported an Operating Profit of 1.02M with an Operating Margin of 0.78% this period, representing a decline of 90.68% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 4183's revenue growth?

    In the latest financial report, 福永生技 (4183) announced revenue of 130.57M, with a Year-Over-Year growth rate of 26.96%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 4183 have?

    At the end of the period, 福永生技 (4183) held Total Cash and Cash Equivalents of 109.95M, accounting for 0.21 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 4183 go with three margins increasing?

    In the latest report, 福永生技 (4183) achieved the “three margins increasing” benchmark, with a gross margin of 17.68%%, operating margin of 0.78%%, and net margin of 4.94%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 4183's profit trajectory and future growth potential.

  • What is the FCF of 4183?

    福永生技 (4183)'s Free Cash Flow (FCF) for the period is 2.47M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 270.6% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.